APA (7th ed.) Citation

Ulrich-Pur, H., Raderer, M., Kornek, G., Schüll, B., Schmid, K., Haider, K., . . . Schüll, B. (2003). Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma. British Journal of Cancer, 88(8), 1180. https://doi.org/10.1038/sj.bjc.6600883

Chicago Style (17th ed.) Citation

Ulrich-Pur, H., et al. "Irinotecan Plus Raltitrexed Vs Raltitrexed Alone in Patients with Gemcitabine-pretreated Advanced Pancreatic Adenocarcinoma." British Journal of Cancer 88, no. 8 (2003): 1180. https://doi.org/10.1038/sj.bjc.6600883.

MLA (9th ed.) Citation

Ulrich-Pur, H., et al. "Irinotecan Plus Raltitrexed Vs Raltitrexed Alone in Patients with Gemcitabine-pretreated Advanced Pancreatic Adenocarcinoma." British Journal of Cancer, vol. 88, no. 8, 2003, p. 1180, https://doi.org/10.1038/sj.bjc.6600883.